Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment.

Memorias do Instituto Oswaldo Cruz - 1 Nov 2007

Bongertz Vera, Ouverney E Priscilla, Fernandez Saada Chequer, Grinsztejn Beatriz, Veloso Valdilea, Couto-Fernandez José C, Pilotto José H, Morgado Mariza G

Abstract excerpt

Highly active antiretroviral treatment (HAART) of human immunodeficiency type 1 (HIV-1) infection is very effective in controlling infection, but elimination of viral infection has not been achieved as yet, and upon treatment interruption an immediate rebound of viremia is observed. A combination of HAART with an immune stimulation might allow treatment interruption without this rebounding viremia, as the very...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Antibodies

Share to HIV Infections

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 18060317
DOI: 10.1590/s0074-02762007005000119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment.PMID 18060317Read ↗

HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.Semantic proximity Read ↗

Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.Semantic proximity Read ↗

Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.Semantic proximity Read ↗

Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesSemantic proximity Read ↗

Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.Semantic proximity Read ↗

V3 peptide binding pattern and HIV-1 transmission route in Rio de Janeiro.Semantic proximity Read ↗

HIV-1 binding and neutralizing antibodies of injecting drug users.Semantic proximity Read ↗

Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.Semantic proximity Read ↗

Evaluation of HIV-1 and CD4+ T cell dynamic parameters in patients treated with genotypic resistance testing-guided HAART.Semantic proximity Read ↗

Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.Semantic proximity Read ↗

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.Semantic proximity Read ↗

Human immunodeficiency virus type 1 Brazilian subtype B variant showed an increasing avidity of the anti-V3 antibodies over time compared to the subtype B US/European strain in São Paulo, Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.